611 related articles for article (PubMed ID: 33266216)
1. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
3. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
4. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
[TBL] [Abstract][Full Text] [Related]
7. Aptamers in targeted nanotherapy.
Mathew A; Maekawa T; Sakthikumar D
Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
9. Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles.
Zununi Vahed S; Fathi N; Samiei M; Maleki Dizaj S; Sharifi S
J Drug Target; 2019 Mar; 27(3):292-299. PubMed ID: 29929413
[TBL] [Abstract][Full Text] [Related]
10. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
[TBL] [Abstract][Full Text] [Related]
11. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
12. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
Guan B; Zhang X
Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.
Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM
Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-conjugated nanomaterials and their applications.
Yang L; Zhang X; Ye M; Jiang J; Yang R; Fu T; Chen Y; Wang K; Liu C; Tan W
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1361-70. PubMed ID: 22016112
[TBL] [Abstract][Full Text] [Related]
17. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted drug delivery with aptamers.
Zhang Y; Hong H; Cai W
Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
